InsidersTradesSigma
Track the Resverlogix Corp. stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares trade on CA CA, under the authority of SEDI. Market capitalisation: €31.7m. The latest transaction was disclosed on 9 July 2026 (56 - Grant of rights). Among the most active insiders: Cann, Aaron Bradley. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
Resverlogix Corp. is a biopharmaceutical company focused on developing treatments for cardiovascular and metabolic diseases. It is listed on the XTSE.